147 search results for: Clinical Management

ESPGHAN 2025 Pediatric EoE: <b>Clinical</b> Data & Long-Term <b>Management</b>
Gastroenterology
ESPGHAN 2025 Pediatric EoE: Clinical Data & Long-Term Management
expert video

Dr Gutiérrez Junquera discusses ESPGHAN guidelines, clinical data, and long-term management strategies for pediatric EoE.

View more
Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation
Dermatology
Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation
expert video

This symposium delves into the pivotal role of type 2 inflammation in diverse skin conditions, including atopic dermatitis, prurigo nodularis, chronic spontaneous urticaria, and bullous pemphigoid. It highlights both shared and distinct disease mechanisms and patient burdens, providing crucial insights for optimizing clinical management strategies through a series of engaging panel discussions with Drs Eichenfield, Elmariah, Culton, and Hawkes.

View more
<b>Clinical</b> Utility of Biomarkers in the <b>Management</b> of AD
Dermatology
Clinical Utility of Biomarkers in the Management of AD
expert video

Dr. Amy Paller discusses the clinical utility of TARC measurements in AD management at EADV 2025

View more
Atopic Dermatitis at an Inflection Point: Refining Outcomes Through Timely, Targeted Intervention
Dermatology
Atopic Dermatitis at an Inflection Point: Refining Outcomes Through Timely, Targeted Intervention
expert video

At the 2026 EADV Congress, Prof. Tilo Biedermann and Drs. Nicole Chase and Lisa Swanson present a holistic view of atopic dermatitis (AD) management from childhood to adulthood centered around type 2 inflammation. Beginning with the hypothesis that reduced exposure to helminths in increasingly industrialized societies may have diminished natural immunomodulatory mechanisms, they explore how dysregulated type 2 inflammation can manifest as AD and extend beyond the skin. The discussion then focuses on adults with uncontrolled AD, highlighting the multidimensional, cumulative burden of disease across the lifespan—and how targeted systemic therapy may help achieve sustained disease control. Finally, the faculty explore pediatric AD as a critical window for early intervention, with the potential to alter disease progression and prevent comorbidities.

View more
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
Dermatology
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
expert video

Dr Lawrence Eichenfield explores the broadening of treatment goals for long-term disease control, highlighting the importance of this approach in atopic dermatitis. Drs Culton, Elmariah, and Hawkes expand the discussion to further examine specific management goals unique to each skin disease (bullous pemphigoid, prurigo nodularis, and chronic spontaneous urticaria).

View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Pulmonology
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Podcast

Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.

View more
Essential Tools for Effective Care of Patients With Chronic Spontaneous Urticaria
Dermatology
Essential Tools for Effective Care of Patients With Chronic Spontaneous Urticaria
expert video

Tune in as Dr. Jason Hawkes describes how to assess disease activity in chronic spontaneous urticaria.

View more
From Data to Decision: Unleashing Real-World Evidence for Smart Treatment Selection 
Dermatology
From Data to Decision: Unleashing Real-World Evidence for Smart Treatment Selection 
expert video

Dr. Pedro Bastos shares how real-world evidence for approved biologics is essential to inform the treatment of PN across diverse comorbid patient populations, including insights into rapid itch relief, progressive skin clearance, long-term outcomes, and safety.

View more
Breaking the Cycle of AD in Adults: Minimizing Cumulative Burden Beyond Skin and Achieving Sustained Disease Control
Dermatology
Breaking the Cycle of AD in Adults: Minimizing Cumulative Burden Beyond Skin and Achieving Sustained Disease Control
expert video

Prof. Tilo Biedermann discusses the key roles of type 2 cytokines IL-4, IL-13, and IL-31 in the pathophysiology of atopic dermatitis. He then describes how these cytokines can be targeted with systemic therapies to elicit long-term disease control and reduce the burden of atopic and non-atopic comorbidities, which are meaningful outcomes for patients with uncontrolled disease.

View more
The Potential Sequelae of Missed Opportunities: How Systemic Type 2 Inflammation Can Shape a Patient's Life
Dermatology
The Potential Sequelae of Missed Opportunities: How Systemic Type 2 Inflammation Can Shape a Patient's Life
expert video

Dr. Nicole Chase describes a potential hypothesis for the link between the shift to an industrialized society and the rise in type 2 inflammatory diseases, highlighting the loss of immunomodulatory mechanisms driven by helminthic infections. She explains how unopposed immune responses to common environmental allergens may cause chronic type 2 inflammation, manifesting throughout the body.

View more